Figures & data
Scheme 1. Experimental design for evaluating the antiproliferative and proapoptotic effects of blueberry anthocyanins and anthocyanidins on B16-F10 cells.
![Scheme 1. Experimental design for evaluating the antiproliferative and proapoptotic effects of blueberry anthocyanins and anthocyanidins on B16-F10 cells.](/cms/asset/29635523-e8cc-49a5-b15c-32d773ec5a06/zfnr_a_1325308_sch0001_c.jpg)
Figure 1. High-performance liquid chromatography chromatograms of anthocyanins and anthocyanidins from blueberry fruits and purified extracts detected at 520 nm. 1, Delphinidin-3-O-galactoside; 2, delphinidin-3-O-glucoside; 3, cyanidin-3-O-galactoside; 4, delphinidin-3-O-arabinoside; 5, cyanidin-3-O-glucoside; 6, petunidin-3-O-galactoside; 7, cyanidin-3-O-arabinoside; 8, petunidin-3-O-glucoside; 9, peonidin-3-O-galactoside; 10, petunidin-3-O-arabinoside; 11, peonidin-3-O-glucoside; 12, malvidin-3-O-galactoside; 13, malvidin-3-O-glucoside; 14, malvidin-3-O-arabinoside; 15, petunidin-3-O-xyloside; 16, malvidin-3-O-xyloside; a, delphinidin; b, cyanidin; c, petunidin; d, peonidin; e, malvidin.
![Figure 1. High-performance liquid chromatography chromatograms of anthocyanins and anthocyanidins from blueberry fruits and purified extracts detected at 520 nm. 1, Delphinidin-3-O-galactoside; 2, delphinidin-3-O-glucoside; 3, cyanidin-3-O-galactoside; 4, delphinidin-3-O-arabinoside; 5, cyanidin-3-O-glucoside; 6, petunidin-3-O-galactoside; 7, cyanidin-3-O-arabinoside; 8, petunidin-3-O-glucoside; 9, peonidin-3-O-galactoside; 10, petunidin-3-O-arabinoside; 11, peonidin-3-O-glucoside; 12, malvidin-3-O-galactoside; 13, malvidin-3-O-glucoside; 14, malvidin-3-O-arabinoside; 15, petunidin-3-O-xyloside; 16, malvidin-3-O-xyloside; a, delphinidin; b, cyanidin; c, petunidin; d, peonidin; e, malvidin.](/cms/asset/875f773e-678c-4c2e-9182-30cc27ba7307/zfnr_a_1325308_f0001_b.gif)
Figure 2. Effects of different concentrations of anthocyanidins, anthocyanins, and doxorubicin on the cell viability of B16-F10 and L929 cells at 24 h, 48 h, and 72 h based on the MTT assay (A–F), and the corresponding median inhibitory concentration (IC50) values (G, H). Data are presented as mean ± SD (n = 6). *p < 0.05 compared with the anthocyanidin-treated group.
![Figure 2. Effects of different concentrations of anthocyanidins, anthocyanins, and doxorubicin on the cell viability of B16-F10 and L929 cells at 24 h, 48 h, and 72 h based on the MTT assay (A–F), and the corresponding median inhibitory concentration (IC50) values (G, H). Data are presented as mean ± SD (n = 6). *p < 0.05 compared with the anthocyanidin-treated group.](/cms/asset/7c479400-f25b-40c9-891c-ba24fa5e6c15/zfnr_a_1325308_f0002_c.jpg)
Figure 3. Morphology of B16–F10 cells by calcein acetoxymethyl ester/propidium iodide fluorescein staining. Cells were treated with anthocyanidins (A1–A6) and anthocyanins (B1–B6) at various concentrations (25–800 μg/mL) for 48 h. Non-treated B16-F10 cells served as the negative control (C1), while doxorubicin was the positive control (D1–D3). The fluorescence images were obtained by inverted fluorescence microscopy.
![Figure 3. Morphology of B16–F10 cells by calcein acetoxymethyl ester/propidium iodide fluorescein staining. Cells were treated with anthocyanidins (A1–A6) and anthocyanins (B1–B6) at various concentrations (25–800 μg/mL) for 48 h. Non-treated B16-F10 cells served as the negative control (C1), while doxorubicin was the positive control (D1–D3). The fluorescence images were obtained by inverted fluorescence microscopy.](/cms/asset/863f94e3-701a-459a-b5ed-5c73d3a95bad/zfnr_a_1325308_f0003_c.jpg)
Figure 4. Flow cytometric analysis of the cell cycle in B16–F10 cells treated with blueberry anthocyanidins (A1–A6, E1) and anthocyanins (B1–B6, E2) at various concentrations (50–800 μg/mL) after 48 h. Non-treated B16–F10 cells served as the negative control (C1), while doxorubicin was the positive control (D1–D3, E3).
![Figure 4. Flow cytometric analysis of the cell cycle in B16–F10 cells treated with blueberry anthocyanidins (A1–A6, E1) and anthocyanins (B1–B6, E2) at various concentrations (50–800 μg/mL) after 48 h. Non-treated B16–F10 cells served as the negative control (C1), while doxorubicin was the positive control (D1–D3, E3).](/cms/asset/b854492b-a970-4a8b-8d45-a7103a8d0570/zfnr_a_1325308_f0004_c.jpg)
Figure 5. Annexin V–fluorescein isothiocyanate/propidium iodide flow cytometric analysis of cell apoptosis in B16–F10 cells in the presence of blueberry anthocyanidins (A1–A6, E1) and anthocyanins (B1–B6, E2) at various concentrations (50–800 μg/mL) after 48 h. Non-treated B16–F10 cells served as the negative control (C1), while doxorubicin was the positive control (D1–D3, E3). Q1, necrotic cells; Q2, cells in the stage of late apoptosis; Q3, viable cells; Q4, early apoptotic cells.
![Figure 5. Annexin V–fluorescein isothiocyanate/propidium iodide flow cytometric analysis of cell apoptosis in B16–F10 cells in the presence of blueberry anthocyanidins (A1–A6, E1) and anthocyanins (B1–B6, E2) at various concentrations (50–800 μg/mL) after 48 h. Non-treated B16–F10 cells served as the negative control (C1), while doxorubicin was the positive control (D1–D3, E3). Q1, necrotic cells; Q2, cells in the stage of late apoptosis; Q3, viable cells; Q4, early apoptotic cells.](/cms/asset/c956f1f6-7c68-4c2d-a515-97200f0b96e0/zfnr_a_1325308_f0005_c.jpg)